Relay Therapeutics Advances Zovegalisib Clinical Data
CAMBRIDGE, Mass., April 2, 2026 Relay Therapeutics, Inc. announced that it will present initial clinical and preclinical data for...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
CAMBRIDGE, Mass., April 2, 2026 Relay Therapeutics, Inc. announced that it will present initial clinical and preclinical data for...
